Methenolone Enanthate — Primobolan 200 by Dragon Pharma
Primobolan 200 is Dragon Pharma's high-concentration formulation of Methenolone Enanthate at 200mg/ml — the same active compound as Primobolan 100 at twice the concentration per ml. For full scientific background on Methenolone's properties — including why it doesn't aromatise, its unique oral bioavailability, its reduced HPG suppression profile and its history — see the Primobolan 100 page. This page focuses on the practical case for the 200mg/ml formulation.
Also searched as: Methenolone Enanthate 200mg, Primobolan 200, Primo 200 Dragon Pharma, high-concentration Primobolan.
Why 200mg/ml — The Dose Economics Argument
Primobolan's modest anabolic ratio (88) means effective performance doses start at 400mg/week and often extend to 600-1000mg/week in experienced users. The concentration difference between 100mg/ml and 200mg/ml becomes operationally significant at these doses:
| Weekly Dose | Primobolan 100 (volume) | Primobolan 200 (volume) | Injections per week (2x/week split) |
|---|---|---|---|
| 400 mg/week | 4 ml/week | 2 ml/week | 2ml vs 1ml per injection |
| 600 mg/week | 6 ml/week | 3 ml/week | 3ml vs 1.5ml per injection |
| 800 mg/week | 8 ml/week | 4 ml/week | 4ml vs 2ml per injection |
At 600mg/week with Primobolan 100, each twice-weekly injection is 3ml — a volume that is uncomfortable and impractical for a single injection site. With Primobolan 200, the same 600mg/week requires only 1.5ml per injection — a manageable single-site volume. For users running Primobolan at 600mg/week or above, the 200mg/ml formulation is practically essential.
The High-Dose Primobolan Rationale
Why do experienced users run Primo at 600-1000mg/week when the anabolic ratio is only 88?
- Methenolone's anabolic ratio understates its practical effect at the receptor level in certain tissue — in-vitro assays on which ratios are based don't fully capture in-vivo tissue-specific activity
- At high doses, Primobolan's mild suppression advantage is lost to some degree — but the lack of aromatisation, minimal androgenic side effects and non-hepatotoxic profile remain intact regardless of dose
- The combination of high Primobolan dose + moderate testosterone provides a unique stack: high total anabolic load from Primobolan's volume combined with testosterone's stronger AR binding for strength and androgenic function
- The "more Primo, less testosterone" approach at higher total doses reduces estrogen burden (since Primobolan doesn't aromatise) while maintaining meaningful anabolic activity — particularly valuable in pre-competition lean mass phases
Effects and Benefits
- Identical compound profile to Primobolan 100 — same Methenolone Enanthate properties
- Twice the concentration — half the injection volume for equivalent weekly doses
- Practical for doses above 400mg/week where 100mg/ml formulation creates uncomfortable injection volumes
- Same no-aromatisation, mild suppression, lean mass quality profile
Dosage and Administration
| Use Case | Weekly Dose | Volume at 200mg/ml | Frequency |
|---|---|---|---|
| Standard performance | 400–600 mg/week | 2–3 ml/week | Twice weekly (1–1.5ml per injection) |
| High-dose protocol | 600–1,000 mg/week | 3–5 ml/week | Twice weekly (1.5–2.5ml per injection) |
Building a Cycle Around Primobolan 200
- Enantat 250 at 250-500mg/week as testosterone base — matched long-ester, same twice-weekly injection day
- Masteron 200 for a fully non-aromatising lean mass trio: Primo 200 + Masteron 200 + Test E for maximum quality mass with minimum estrogen burden
- Clomid or Nolvadex for PCT — lighter PCT than after more suppressive compounds
"Primobolan 200 is the practical formulation for users running 600mg/week or above — halving injection volume from the 100mg/ml version makes high-dose Primobolan protocols viable without 3-4ml per injection site."
Storage and Handling
Store Primobolan 200 at room temperature away from direct sunlight and heat. Use sterile technique for every draw.